ID: ALA1788114

Max Phase: Preclinical

Molecular Formula: C9H13NO

Molecular Weight: 151.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](N)[C@H](O)c1ccccc1

Standard InChI:  InChI=1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3/t7-,9+/m1/s1

Standard InChI Key:  DLNKOYKMWOXYQA-APPZFPTMSA-N

Associated Targets(non-human)

Phenylethanolamine N-methyltransferase 752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 151.21Molecular Weight (Monoisotopic): 151.0997AlogP: 1.07#Rotatable Bonds: 2
Polar Surface Area: 46.25Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.90CX Basic pKa: 9.37CX LogP: 0.89CX LogD: -1.05
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.66Np Likeness Score: 0.57

References

1. Grunewald GL, Ye QH..  (1988)  Stereochemical aspects of phenylethanolamine analogues as substrates of phenylethanolamine N-methyltransferase.,  31  (10): [PMID:3172133] [10.1021/jm00118a021]

Source